Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Bio Key International (BKYI) over the last 17 years, with Q3 2025 value amounting to $10.1 million.

  • Bio Key International's Liabilities and Shareholders Equity rose 5802.78% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.4 million, marking a year-over-year increase of 10331.79%. This contributed to the annual value of $8.6 million for FY2024, which is 9073.49% up from last year.
  • Per Bio Key International's latest filing, its Liabilities and Shareholders Equity stood at $10.1 million for Q3 2025, which was up 5802.78% from $10.5 million recorded in Q2 2025.
  • In the past 5 years, Bio Key International's Liabilities and Shareholders Equity ranged from a high of $21.5 million in Q1 2021 and a low of $4.2 million during Q1 2024
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $10.5 million (2025), whereas its average is $12.0 million.
  • In the last 5 years, Bio Key International's Liabilities and Shareholders Equity surged by 61153.25% in 2021 and then tumbled by 6040.61% in 2023.
  • Over the past 5 years, Bio Key International's Liabilities and Shareholders Equity (Quarter) stood at $17.8 million in 2021, then tumbled by 36.16% to $11.3 million in 2022, then plummeted by 60.18% to $4.5 million in 2023, then skyrocketed by 90.73% to $8.6 million in 2024, then increased by 17.38% to $10.1 million in 2025.
  • Its last three reported values are $10.1 million in Q3 2025, $10.5 million for Q2 2025, and $11.2 million during Q1 2025.